Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

NCT00533442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Rapamycin
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Steroids

Sponsor

University of Miami

Collaborators

[object Object]